NOVAVAX INC (NVAX) Revenue 2016–2025
NOVAVAX INC (NVAX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1BFY2025 · since FY2016: $15.4M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +64.7% |
| FY2024 | $682.2M | -30.7% |
| FY2023 | $983.7M | -50.4% |
| FY2022 | $2.0B | +72.9% |
| FY2021 | $1.1B | +141.0% |
| FY2020 | $475.6M | +2448.5% |
| FY2019 | $18.7M | -45.6% |
| FY2018 | $34.3M | +10.0% |
| FY2017 | $31.2M | +103.1% |
| FY2016 | $15.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX Net incomeNVAX Net marginNVAX Gross profitNVAX Gross marginNVAX Operating incomeNVAX Operating marginNVAX Operating cash flowNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →